Vimarsana
Biggest News Aggregation in the World

Dimagi Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dimagi Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dimagi Inc Today - Breaking & Trending Today

PMI VectorLink: Six Years of Malaria Vector Control Achievements - Vimarsana News

PMI VectorLink: Six Years of Malaria Vector Control Achievements

Malaria, one of the world’s deadliest diseases, is transmitted by one of the world’s smallest insects—the mosquito.

Abt Associates Awarded Contract to Prevent Malaria through Vector Control - Vimarsana News

Abt Associates Awarded Contract to Prevent Malaria through Vector Control

Rockville MD (PRWEB) January 05, 2023 -- The U.S. Agency for International Development (USAID), the lead agency for the U.S. President’s Malaria Initiative

Source: prweb.com
Dimagi to Launch Monkeypox Case Management Solution to Support US Public Health Departments - Vimarsana News

Dimagi to Launch Monkeypox Case Management Solution to Support US Public Health Departments

Digital template application powered by CommCare for investigating monkeypox cases and tracing contacts to be offered free for 6 months to control...

Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial | BMC Infectious Diseases - Vimarsana News

Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial | BMC Infectious Diseases

Azithromycin is a broad-spectrum antibiotic that has moderate antimalarial activity and has been shown to reduce all-cause mortality when biannually administered to children under five in high mortality settings in sub-Saharan Africa. One potential mechanism for this observed reduction in mortality is via a reduction in malaria transmission. We evaluated whether a single oral dose of azithromycin reduces malaria positivity by rapid diagnostic test (RDT). We conducted an individually randomized placebo-controlled trial in Burkina Faso during the high malaria transmission season in August 2020. ...

Sickle Cell Foundation Of Ghana Expresses Appreciation To Government For Its Decision On Hydroxyurea For Treatment Of Sickle Cell Disease - Vimarsana News

Sickle Cell Foundation Of Ghana Expresses Appreciation To Government For Its Decision On Hydroxyurea For Treatment Of Sickle Cell Disease

  On World Sickle Cell Day (19th June 2021) the Vice President of the Republic of Ghana, His Excellency Dr. Mahamudu Bawumia, announced through his Facebook and Instagram pages that hydroxyurea, a disease-modifying therapy for sickle cell disease (SCD) will now be provided under the National Health Insurance Scheme (NHIS) to improve the health of people living with SCD in Ghana.  This announcement followed a meeting he convened on 8th June 2021, with stakeholders including Professor Kwaku Ohene-Frempong, President of the Sickle Cell Foundation of Ghana (Foundation), Hon. Kwaku Agyemang-Man...